Gregory B. Abbott

AmideBio LLC operates as a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. Its products include amyloid peptides, amyloid kits & buffers, brazzeins, toxins and knottins. The company was founded by Mikhail Plam and Michael H. B. Stowell and is headquartered in Louisville, CO.

Cooley Goodword LLP is the law firm specializes in providing services to both new and established information technology and life sciences companies. Cooley also provides counsel in areas of business law that include trade regulation, employment and labor, investment banking issues, securities litigation, IPOs, mergers and acquisitions, patent enforcement and venture capital funding. It is located in Palo Alto, CA.

Part of Sanofi, Selectide Corp. is a pharmaceutical research firm. The private company is based in Tucson, AZ. The company was founded by Stephen Ralfe Evans-Freke. Selectide was acquired by Marion Merrell Dow, Inc. on January 27, 1995 for $58 million.

diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field.

Part of UCB SA, Darwin Molecular Corp is a biotechnology research and development firm. The private company is based in Bothell, WA. Darwin Molecular was acquired by Celltech Group Plc on November 20, 1996 for $120 million.